How South Korea's Regulatory Innovations are Shaping the Global Bio Market in 2026
AI 요약 정보
- Kim says ministry targets 240-day reviews for new drugs
- Ministry plans AI medicine rules and CDMO export support
- South Korea joins ICMRA executive committee this year